Novavax
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Novavax's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 38% to $983,705,000. The net income raised on -$545,062,000 and profit margin reached -55%. Total operating expenses were $779,125,000.
Profit Margin
| 2014 | 30.65M | -82.94M | -270.55% |
|---|---|---|---|
| 2015 | 36.25M | -156.93M | -432.93% |
| 2016 | 15.35M | -279.96M | -1823.53% |
| 2017 | 31.17M | -183.76M | -589.46% |
| 2018 | 34.28M | -184.74M | -538.81% |
| 2019 | 18.66M | -130.10M | -697.15% |
| 2020 | 475.59M | -427.50M | -89.89% |
| 2021 | 1.14B | -1.74B | -152.12% |
| 2022 | 1.59B | -657.93M | -41.15% |
| 2023 | 983.70M | -545.06M | -55.41% |
NVAX Income Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 983.70M | 1.59B | 1.14B | 475.59M | 18.66M | 34.28M | 31.17M | 15.35M | 36.25M | 30.65M |
Cost of revenue | 343.76M | 902.63M | 12.66M | 747.02M | 113.84M | 0 | 0 | 237.93M | 162.64M | 14.98M |
Gross profit | 639.93M | 696.31M | 1.13B | -271.42M | -95.18M | 34.28M | 31.17M | -222.58M | -126.39M | 15.67M |
Operating exp. | ||||||||||
Research and development | 737.50M | 1.23B | 2.53B | 747.02M | 113.84M | 173.79M | 168.43M | 237.93M | 162.64M | 79.43M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 779.12M | 1.34B | 2.83B | 892.31M | 148.25M | 208.20M | 202.88M | 284.46M | 193.48M | 99.36M |
Operating income | -566.51M | -644.73M | -1.68B | -416.71M | -120.58M | -173.91M | -171.71M | -269.11M | -157.23M | -83.69M |
Other income (expenses), net | 23.48M | -8.91M | -27.96M | -1.54M | -12.11M | 108K | -12.05M | -31K | 299K | 744K |
Income before tax | -543.03M | -653.64M | -1.71B | -418.25M | -132.69M | -184.74M | -183.76M | -279.96M | -156.93M | -82.94M |
Income tax expense | 2.03M | 4.29M | 29.21M | 9.24M | -2.59M | 1.35M | 2.30M | 2.31M | -6.40M | -5.16M |
Net income | -545.06M | -657.93M | -1.74B | -427.50M | -130.10M | -184.74M | -183.76M | -279.96M | -156.93M | -82.94M |
Earnings per share | ||||||||||
Basic EPS | -5.41 | -8.42 | -23.44 | -7.43 | -5.4 | -9.99 | -12.56 | -20.68 | -11.97 | -7.35 |
Diluted EPS | -5.41 | -8.42 | -23.44 | -7.43 | -5.4 | -9.99 | -12.56 | -20.68 | -11.97 | -7.35 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |